EssilorLuxottica Société anonyme (EPA:EL)
France · Delayed Price · Currency is EUR 239.30
+2.20 (0.93%)
At close: Feb 26, 2026
EPA:EL Revenue
In the year 2025, EssilorLuxottica Société anonyme had annual revenue of 28.49B EUR with 7.48% growth. EssilorLuxottica Société anonyme had revenue of 14.47B in the half year ending December 31, 2025, with 15.33% growth.
Revenue
28.49B
Revenue Growth
+7.48%
P/S Ratio
3.89
Revenue / Employee
142.46K
Employees
200,000
Market Cap
110.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.49B | 1.98B | 7.48% |
| Dec 31, 2024 | 26.51B | 1.11B | 4.38% |
| Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
| Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
| Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| Eurofins Scientific SE | 7.30B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| Ramsay Générale de Santé | 5.24B |
| bioMérieux | 4.12B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
EssilorLuxottica Société anonyme News
- 2 days ago - Meta (META) and EssilorLuxottica Discuss Pricing Strategies for Smart Glasses - GuruFocus
- 9 days ago - EssilorLuxottica CFO: AI Glasses Gaining Strong Momentum - CNBC
- 10 days ago - EssilorLuxottica: Disclosure of transactions in own shares - GlobeNewsWire
- 12 days ago - EssilorLuxottica: Turning Positive On Market-Share Gain (Rating Upgrade) - Seeking Alpha
- 13 days ago - President Trump's Tariffs To Face Feb.20 Supreme Court Hearing As Prediction Markets Doubt Favorable Ruling - Benzinga
- 13 days ago - EssilorLuxottica announces the launch of a share buyback program - GlobeNewsWire
- 14 days ago - EssilorLuxottica (ESLOF) Reports Strong FY Revenue Growth and Dividend Proposal - GuruFocus
- 14 days ago - EssilorLuxottica Shares Gain as Smartglasses Promise Rosy Future - WSJ